PMS2 - Estimating the Budget Impact in Brazilian Public Health Care System of Tocilizumab Reimbursement As a Rheumatoid Arthritis First-Line Biological Therapy

Autor: Tsuchiya, C.T., Tobaruella, F.S., Ramos, L.A., Buschinelli, C.T., Maximo, M.F.M., Gonçalves, T.M.
Zdroj: In Value in Health November 2013 16(7):A715-A715
Databáze: ScienceDirect
Externí odkaz: